Working... Menu
Trial record 16 of 112 for:    mf59

Safety and Immune Response to a Clade C DNA HIV Vaccine (HVTN111)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02997969
Recruitment Status : Completed
First Posted : December 20, 2016
Last Update Posted : June 21, 2019
HIV Vaccine Trials Network
IPPOX Foundation
Novartis Vaccines
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 11, 2018
  Actual Study Completion Date : July 11, 2018